Chinese patent medicine combined with calcium channel blockers in the treatment of essential hypertension:a Bayes network meta-analysis and systematic review

• Main Authors: Liangyu Cui (Author), Xingfang Liu (Author), Yukun Li (Author), Tianyue Jing (Author), Dasheng Liu (Author), Cong Ren (Author), Tong Yin (Author), Yu Wang (Author), Zhiwei Zhao (Author), Jiaheng Wang (Author), Xuejie Han (Author), Liying Wang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Backgroud: The co-administration of Chinese patent medicine with calcium channel blockers (CCBs) is a prevalent practice in China for treating essential hypertension (EH). However, robust evidence supporting the efficacy and safety of tailored combinations of different Chinese patent medicines with...